Share the Savings
On average, biopharmaceutical companies rebate 40% of a medicine’s list price back to health insurance and pharmacy benefit managers, but these discounts are not reaching patients. If these discounts and coupons are available for insurance companies and other middlemen, then they also need to be available to patients at the pharmacy counter.
Offer Lower, More Predictable Cost-Sharing Options
Patients should have more choices when it comes to their medicine coverage. Spending on brand medicines is growing at the slowest rate in years, but insurers are using high deductibles, coinsurance and formulary tiers that result in patients paying more out of pocket at the pharmacy counter.